Pocan Announces Kathy Honerbaum as State of the Union Guest
Honerbaum, a retired ER nurse of over 50 years in Dodgeville, was diagnosed with breast cancer last year, and prescribed Ibrance, a $13,000 drug with a $2,800 copay.
WASHINGTON, DC – U.S. Representative Mark Pocan (WI-02) today announced Kathy Honerbaum, a retired nurse of over 50 years in Dodgeville, as his guest for the State of the Union. Honerbaum, after recently being diagnosed with breast cancer, was prescribed Ibrance, a $13,000 per month drug, with a $2,800 copay with Medicare Part D. If H.R. 3, the Lower Drug Costs Now Act, were passed, Ibrance would be included in the list of drugs to be negotiated because it is the seventeenth-most costly drug to Medicare part D.
For months, Honerbaum could not afford Ibrance, despite repeated attempts to request financial support from the drug’s manufacturer, Pfizer. Honerbaum finally cut back on her working hours and entered an early retirement, so that she could meet the low-income threshold Pfizer has set for drug waivers. Finally, the pharmaceutical company covered the cost of her drug, but months later she found out the drug was not working. Luckily, her new drug, Xeloda, has no co-pay. Everyone isn’t so ‘lucky.’
“No one should have to go through what I had to go through to afford medication that could help save a life,” said Kathy Honerbaum. “It is appalling that even basic medication like insulin costs families thousands of dollars. After pouring my heart out to Pfizer, I was lucky to have my drug covered, but luck should have nothing to do with our healthcare.”
The Lower Drug Costs Now Act, which passed in the House in December, is sweeping legislation that would dramatically reduce drug prices by giving Medicare the power to negotiate directly with drug companies, ensuring lower drug prices for Americans. The bill would give the Department of Health and Human Services the power to negotiate on 50 of the highest cost and highest utilized drugs, including Ibrance.
Mentioned in This Press Release
Recent Press Releases by U.S. Rep Mark Pocan